Evidence map›Paper›PMID 27056076›Full record

ArticleMolecular neurobiology2017

Mutation Screening of the CHCHD10 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis.

QingQing Zhou, YongPing Chen, QianQian Wei, Bei Cao, Ying Wu, Bi Zhao, RuWei Ou, Jing Yang, XuePing Chen, Shinji Hadano and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Combined impact ofFrontiers in neurology · 2025
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. MNRR1, a Biorganellar Regulator of Mitochondria.Oxidative medicine and cellular longevity · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

QingQing ZhouDepartment of Neurology, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.
YongPing ChenDepartment of Neurology, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.
QianQian WeiDepartment of Neurology, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.
Bei CaoDepartment of Neurology, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.
Ying WuDepartment of Neurology, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.
Bi ZhaoDepartment of Neurology, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.
RuWei OuDepartment of Neurology, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.
Jing YangDepartment of Neurology, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.
XuePing ChenDepartment of Neurology, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.
Shinji HadanoDepartment of Molecular Life Sciences, Tokai University School of Medicine, Isehara, Kanagawa, Japan. shinji@is.icc.u-tokai.ac.jp.
Hui-Fang ShangDepartment of Neurology, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China. hfshang2002@126.com.
Sichuan University · CNWest China Hospital of Sichuan University · CNTokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in the coiled-coil-helix-coiled-coil-helix domain-containing protein 10 gene (CHCHD10), involved in mitochondrial function, have recently been reported as a causative gene of amyotrophic lateral sclerosis (ALS). The aim of this study was to obtain the mutation prevalence of CHCHD10 and the phenotypes with mutations in Chinese ALS patients. A cohort of 499 ALS patients including 487 sporadic ALS (SALS) and 12 familial ALS (FALS), from the Department of Neurology, West China Hospital of Sichuan University, were screened for mutations of all exons of the CHCHD10 gene by Sanger sequencing. Novel candidate mutations or variants were confirmed by polymerase chain reaction-restriction fragment length polymorphism in 466 healthy individuals. All patients identified with mutations of CHCHD10 gene were screened for mutations of the common ALS causative genes including C9orf72, SOD1, TARDBP, FUS, PFN1, and SQSTM1. Three heterozygous variants, including two missense mutations (c.275A > G (p.Y92C) and c.306G > C (p.Q102H)) and a synonymous change c.306G > A (p.Q102Q), were found in exon 3 of CHCHD10 in three alive SALS individuals (with the longest disease duration of 8.6 years), all of which were not detected in healthy controls. No mutation in CHCHD10 was identified in FALS patients. No mutation was found in the aforementioned common ALS causative genes in the patients who carried CHCHD10 mutations. The mutation frequency of CHCHD10 (0.4 %, 2/487) in a Chinese SALS population suggests CHCHD10 gene mutation appears to be an uncommon cause of ALS in Chinese populations. CHCHD10 mutations are associated with a slow progression and long disease duration.

Indexed as

Genetic Predisposition to DiseaseAmino Acid SequenceAmyotrophic Lateral SclerosisAsian PeopleBase SequenceCase-Control StudiesDemographyDNA Mutational AnalysisFemaleHumansMaleMiddle AgedMitochondrial ProteinsCHCHD10 protein, humanMitochondrial ProteinsAmyotrophic lateral sclerosisCHCHD10ChineseMutation

Identifiers

PMID27056076
OpenAlexW2328293158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.